Okan BARİ, Özgür SÖĞÜT, Sümeyye ÇAKMAK, Onur KAPLAN

Migren Atak ile Acil Servise Başvuran Hastaların İlk Değerlendirilmesinde C-Reaktif Protein/Albumin Oranı

Amaç: Bu çalışmada, migren atağına bağlı başağrısı şikayetiyle acil servise (AS) başvuran hastalarda ilk başvuruda ölçülen serum C-Reaktif Protein (CRP)/Albumin ve Nötrofil/lenfosit (NLO) oranlarının, MIDAS (Migrene bağlı iş kaybı değerlendirme ölçeği) skoru ile ölçülen migren ilişkili iş göremezlik durumunun derecesini tahmin etmedeki rolünün araştırılması amaçlanmıştır.

Anahtar Kelimeler:

CRP/Albumin, NLO, MIDAS, auralı migren, aurasız migren

C-Reactive Protein/Albumin Ratio in the Initial Evaluation of Patients with Migraine Attack Presented to the Emergency Department

Aim: In this study, we aimed to investigate the role of serum C-Reactive Protein (CRP)/Albumin and neutrophil to lymphocyte (NRL) ratios measured in the initial evaluation of patients admitted to the emergency department (ED) with a headache due to migraine attack, in estimating the migraine-related disability that was measured by the Migraine Disability Assessment Scale (MIDAS) score.

Keywords:

CRP/Albumin, NRL, MIDAS, migraine with aura, migraine without aura,

PDF

___

Özge A, Karadaş A. Headache classifications. Turkiye Klinikleri J Neurol-Special Topics. 2018;11(1):1-14.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd-Edition-2018.pdf. Cephalalgia. 2018;38(1):1-211.
Global Burden of Disease Study 2010 (GBD2010) Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd- Edition-2018.pdf. Cephalalgia. 2018;38(1):1-211.
Global Burden of Disease Study 2015 (GBD2015) Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd- Edition-2018.pdf. Cephalalgia. 2018;38(1):1-211.
Matowicka-Karna J. Markers of inflammation, activation of blood platelets and coagulation disorders in inflammatory bowel diseases. Postepy Hig Med Dosw (Online) 2016;70:305-12.
Geyik S, Altunısık E, Neyal AM, Taysi S. Oxidative stress and DNA damage in patients with migraine. J Headache Pain. 2016;17:10.
Eren Y, Dirik E, Neşelioğlu S, Erel Ö. Oxidative stress and decreased thiol level in patients with migraine: Cross-sectional study. Acta Neurol Belg. 2015;115(4):643–49.
Lance JW. Current concepts of migraine pathogenesis. Neurology. 1993;43(6 Suppl 3):S11–15.
Kallela M, Färkkilä M, Saijonmaa O, Fyhrquist F. Endothelin in migraine patients. Cephalalgia. 1998;18(6):329–32.
Kinoshita A, Onoda H, Imai N, Nishino H, Tajiri H. C-reactive protein as a prognostic marker in patients with hepatocellular carcinoma. Hepatogastroenterology. 2015;62(140):966-70.
Lelubre C, Anselin S, Zouaoui Boudjeltia K, Biston P, Piagnerelli M. Interpretation of C-reactive protein concentrations in critically ill patients. Biomed Res Int. 2013;2013:124021.
Avci AY, Lakadamyali H, Arikan S, Benli US, Kilinc M. High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients. J Headache Pain. 2015;16:9.
Goh SL, De Silva RP, Dhital K, Gett RM. Is low serum albumin associated with postoperative complications in patients undergoing oesophagectomy for oesophageal malignancies? Interact Cardiovasc Thorac Surg. 2015;20:107-13.
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387-97.
Kaplan M, Ates I, Akpinar MY, Yuksel M, Kuzu UB, Kacar S, et al. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2017;16(4):424-430.
Wada H, Dohi T, Miyauchi K, Doi S, Naito R, Konishi H, et al. Independent and combined effects of serum albumin and C-reactive protein on long-term outcomes of patients undergoing percutaneous coronary intervention. Circ J. 2017;81(9):1293-1300.
Stewart WF, Lipton RB, Whyte J, Dawson A, Kolodner K, Liberman JN, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999;53(5):988-994.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
Özdemir G, Aygül R, Demir R, Özel L, Ertekin A, Ulvi H. Migraine prevalence, disability, and sociodemographic properties in the eastern region of Turkey: A population-based door-to-door survey. Turk J Med Sci. 2014;44(4):624-9.
Aygül R, Deniz O, Güzelcik M, Şahin A. Migrenli hastaların sosyodemografik özellikleri. The Eurasian J Med. 2001;33:91-6.
Aygul R, Deniz O, Kocak N, Orhan A, Ulvi H. The clinical properties of a migraineuse population in Eastern Turkey-Erzurum. South Med J. 2005;98(1):23-7.
Wacogne C, Lacoste JP, Guillibert E, Hugues FC, Le Jeunne C. Stress, anxiety, depression and migraine. Cephalalgia. 2003;23(6): 451-5.
Ertas M, Baykan B, Orhan EK, Zarifoğlu M, Karli N, Saip S, et al. One-year prevalence and the impact of migraine and tension-type headache in Turkey: A nationwide home-based study in adults. J Headache Pain. 2012;13:147-57.
Welch K, Brandes A, Salerno L, Brandes J. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache. 2006; 46:197-199.
Guldiken B, Guldiken S, Demir M, Turgut N, Kabayel L, Ozkan H, et al. Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci. 2008;35:448-51.
Rockett FC, Perla Ada S, Perry ID, Chaves ML. Cardiovascular disease risk in women with migraine. J Headache Pain. 2013;14:75.
Tekeşin A, Tunç A. Evaluation of inflammatory markers in patients with migraine. Arch Clin Exp Med. 2019;4(1):37-40.